With Dupixent's Patent Clock Ticking, Sanofi Circles Insmed

Source: Benzinga ·

With Dupixent's Patent Clock Ticking, Sanofi Circles Insmed

Insmed Inc. (NASDAQ:INSM) stock surged Thursday following a report that French pharmaceutical giant Sanofi SA (NASDAQ:SNY) is exploring a potential acquisition of the respiratory disease specialist. The potential acquisition comes as Sanofi seeks new growth opportunities to reduc

Read the full story at Benzinga

Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.

More from the world desk